Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

5,415.00p
   
  • Change Today:
    -135.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 3,834.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 211,415
  • Market Cap: 3,561.23m
  • RiskGrade: 128

Latest ShareCast News

Genus posts rise in FY profits but warns over hit to growth

By Michele Maatouk

Date: Thursday 09 Sep 2021

(Sharecast News) - Animal genetics company Genus reported a jump in full-year profit and revenue on Thursday as it continued to win new customers, with growth in both of its business, but warned that recent volatility in the Chinese porcine market will dent growth.

Genus Regulatory News

Director/PDMR Shareholding 15-Sep-2021 16:45 RNS
Director/PDMR Shareholding 14-Sep-2021 16:32 RNS
Preliminary Results 09-Sep-2021 07:00 RNS
Total Voting Rights 01-Sep-2021 14:05 RNS
Block listing Interim Review 02-Aug-2021 16:00 RNS

Genus News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 5,415.00p
Change Today -135.00p
% Change -2.43 %
52 Week High 6,070.00
52 Week Low 3,834.00
Volume 211,415
Shares Issued 65.77m
Market Cap 3,561.23m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.75% below the market average99.75% below the market average99.75% below the market average99.75% below the market average99.75% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
59.68% above the market average59.68% above the market average59.68% above the market average59.68% above the market average59.68% above the market average
54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average
Income
64.5% below the market average64.5% below the market average64.5% below the market average64.5% below the market average64.5% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Growth
84.03% above the market average84.03% above the market average84.03% above the market average84.03% above the market average84.03% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 4
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Nov-21 04-Mar-21
Paid 10-Dec-21 01-Apr-21
Amount 21.70p 10.30p

Trades for 28-Sep-2021

Time Volume / Share Price
11:15 41 @ 5,415.00p
11:12 2 @ 5,425.00p
11:12 6 @ 5,425.00p
11:12 37 @ 5,425.00p
11:12 45 @ 5,425.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page